These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 380354)

  • 21. Graft reactions after keratoplasty for keratoconus.
    Chandler JW; Kaufman HE
    Am J Ophthalmol; 1974 Apr; 77(4):543-7. PubMed ID: 4594667
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolonged survival of allogeneic corneal grafts in rabbits treated with topically applied cyclosporin A: systemic absorption and local immunosuppressive effect.
    Foets B; Missotten L; Vanderveeren P; Goossens W
    Br J Ophthalmol; 1985 Aug; 69(8):600-3. PubMed ID: 3893529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental study on cyclosporin A (CsA) acting on rejection of heterolamellar corneal transplantation].
    Xu J; Guo A; Kulkarni P
    Yan Ke Xue Bao; 1990 Dec; 6(3-4):66-72. PubMed ID: 2289577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report.
    Hill JC; Maske R; Watson PG
    Eye (Lond); 1991; 5 ( Pt 4)():420-4. PubMed ID: 1743357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits.
    Guo A; Ohia E; Xu JT; Bhattacherjee P; Kulkarni P
    Curr Eye Res; 1990 Aug; 9(8):749-57. PubMed ID: 2125906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.
    Leibowitz HM; Bartlett JD; Rich R; McQuirter H; Stewart R; Assil K
    Arch Ophthalmol; 1996 Aug; 114(8):933-7. PubMed ID: 8694727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of fluorometholone into the cornea and aqueous humor.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1975 Jun; 93(6):425-7. PubMed ID: 1131082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Induction of unresponsiveness to skin allo- and xenografts by administration of prednisolone and donor antigens].
    Lie TS; Briant R; Müller G; Vogels P
    Wien Klin Wochenschr; 1973 Jan; 85(4):55-9. PubMed ID: 4405330
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluorometholone. Anti-inflammatory and intraocular pressure effects.
    Fairbairn WD; Thorson JC
    Arch Ophthalmol; 1971 Aug; 86(2):138-41. PubMed ID: 5571411
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppression by a subconjunctival implant releasing dexamethasone in a rabbit model of penetrating keratoplasty.
    Crouzet E; Garcin T; Gauthier AS; He Z; Perrache C; Delavenne X; Basset T; Peoc'h M; Gain P; Thuret G
    Br J Ophthalmol; 2018 May; 102(5):692-699. PubMed ID: 29437570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late spontaneous clearing of corneal grafts.
    Baum JL
    Arch Ophthalmol; 1977 Sep; 95(9):1538-9. PubMed ID: 332132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subepithelial infiltrates: a probable sign of corneal transplant rejection.
    Krachmer JH; Alldredge OC
    Arch Ophthalmol; 1978 Dec; 96(12):2234-7. PubMed ID: 363109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroids and immunosuppressive agents in rabbit heterolamellar corneal transplant model.
    Ohia E; Kulkarni P
    Agents Actions; 1991 Sep; 34(1-2):165-8. PubMed ID: 1793023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
    Price MO; Scanameo A; Feng MT; Price FW
    Ophthalmology; 2016 Jun; 123(6):1232-6. PubMed ID: 26983976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results].
    Goichot-Bonnat L; Chemla P; Pouliquen Y
    J Fr Ophtalmol; 1987; 10(3):213-7. PubMed ID: 3301994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid therapy of eye disease. Fifty years later.
    Raizman M
    Arch Ophthalmol; 1996 Aug; 114(8):1000-1. PubMed ID: 8694704
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience.
    Young AL; Rao SK; Cheng LL; Wong AK; Leung AT; Lam DS
    Eye (Lond); 2002 May; 16(3):304-8. PubMed ID: 12032722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical fluorometholone reduces stromal inflammation after photorefractive keratectomy.
    Campos M; Abed HM; McDonnell PJ
    Ophthalmic Surg; 1993 Oct; 24(10):654-7. PubMed ID: 8259241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
    Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
    Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection.
    Tandon R; Verma K; Chawla B; Sharma N; Titiyal JS; Kalaivani M; Vajpayee RB
    Eye (Lond); 2009 Mar; 23(3):635-9. PubMed ID: 18292787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.